Gil Kaplan MD MPH

@gilkaplan

Gastroenterologist & epidemiologist. Professor @UCalgary. Associate Editor, @AGA_Gastro My life's work: http://rdcu.be/cbtoW Tweets are my personal views.

Calgary, Alberta

Joined June 2015

727Following

3KFollowers

Pinned

Gil Kaplan MD MPH@gilkaplan · Apr 30

Open-access @Nature paper from the @IBD_GIVES21 consortium, co-led by @Siew_C_Ng and I, funded by @HelmsleyTrust, and supported by @IOIBD1, reveals the global evolution of IBD across epidemiologic stages. Co–first authors: @dataLindsay & @LingWWindsor nature.com/articles/s4158…

gilkaplan's tweet card. Nature - An analysis of data from 522 population-based studies encompassing 82 global regions and spanning more than a century (1920–2024) shows spatiotemporal transitions across...

109

8.0K

Gil Kaplan MD MPH Retweeted

Cathy Lu@CathyLuMD · Jul 11

@mikedolinger #joellestpierre kicking off IUS train the trainer @ucalgarymed passionately debating is IUS competency based on #'s or skills? @novakkerri 🏆 Best is a combination of skills, proficiency, observed competency and a minimum cut off # IUS. @BowelUltrasound @iUSCAN

652

Gil Kaplan MD MPH@gilkaplan · Jun 27

Once thought to be a condition only seen in Western nations, IBD progression is now found all around the world. Here’s why. healthcentral.com/news/inflammto…

gilkaplan's tweet card. Once thought to be a condition only seen in Western nations, IBD progression is now found all around the world. Here’s why.

5.0K

Gil Kaplan MD MPH Retweeted

Shicheng Guo@ShihchengGuo · Jun 14

IBD, initially a concern for North America, Europe, and Oceania, surged in Africa, Asia, and Latin America in the 21st century, evolving globally. PMID:40307548, Nature 2025, @Nature doi.org/10.1038/s41586… #AI #Pharma #BioMed #RNA #ASHG #ESHG

651

Gil Kaplan MD MPH@gilkaplan · Jun 8

Two @UCalgary linguists walk into an epidemiology lab … The remarkable story of two creative intellectual minds—true embodiments of transdisciplinary academia. @LingJWWindsor @dataLindsay ucalgary.ca/news/two-ucalg…

gilkaplan's tweet card. And the results are no joke. Faculty of Arts alumni Lindsay Hracs and Joseph Windsor lead ground-breaking research paper on the evolution of inflammatory bowel disease

314

Gil Kaplan MD MPH Retweeted

Snyder Institute for Chronic Diseases@SnyderInstitute · May 15

The number of people living with IBD is expected to surge by 2045, according to a new global study published in Nature Portfolio, co-led by Dr. @gilkaplan. msn.com/en-in/health/o… #IBD #HealthcareCrisis #CanadaHealth #IBDCanada @UCalgaryMed @UCalgary @OBrien_IPH

281

Gil Kaplan MD MPH Retweeted

Nature Portfolio@NaturePortfolio · May 4

An analysis in @Nature shows spatiotemporal transitions across epidemiologic stages 1 to 3 of inflammatory bowel disease, and models stage 4 progression. go.nature.com/42FFOtR

11.0K

Gil Kaplan MD MPH@gilkaplan · May 3

On the podium, @LingJWWindsor shared findings from our 5-year journey defining the epidemiologic stages of IBD—now published in @Nature. His latest work shows a narrowing UC:CD ratio across the first three stages in IBD’s evolution. Full story: nature.com/articles/s4158…

gilkaplan's tweet image. On the podium, @LingJWWindsor shared findings from our 5-year journey defining the epidemiologic stages of IBD—now published in @Nature. His latest work shows a narrowing UC:CD ratio across the first three stages in IBD’s evolution. Full story: nature.com/articles/s4158…

759

Gil Kaplan MD MPH@gilkaplan · May 3

Brilliant on the podium, @Stephanie_Epi forecasted that in 9 Stage 3 countries, IBD incidence will reach 30 per 100,000 and prevalence 0.8% by 2025—projected to rise to 1% by 2035. A standout moment from a standout epidemiologist. #DDW2025

gilkaplan's tweet image. Brilliant on the podium, @Stephanie_Epi forecasted that in 9 Stage 3 countries, IBD incidence will reach 30 per 100,000 and prevalence 0.8% by 2025—projected to rise to 1% by 2035. A standout moment from a standout epidemiologist. #DDW2025

1.0K

Gil Kaplan MD MPH Retweeted

Charlie Lees@charlie_lees · May 3

Giants of global IBD line up to ask questions of @DrRupaBanerjee1 #DDW2025 @gilkaplan @Siew_C_Ng @JeanFredericCo1

4.0K

Gil Kaplan MD MPH@gilkaplan · May 1

I want to thank @dataLindsay and @LingJWWindsor co-first authors of the @Nature paper, for their incredible work in synthesizing and analyzing a treasure trove of global epidemiologic data on IBD. Check out this amazing story from @UCalgary: ucalgary.ca/news/research-…

gilkaplan's tweet card. Investigators from UCalgary and Chinese University of Hong Kong say findings point to a major rise in prevalence in Canada by 2045

2.0K

Gil Kaplan MD MPH@gilkaplan · Feb 28

20 years ago, as a GI fellow at the GRIT and CDDW conference, I looked up to mentors at the podium. It’s a true privilege to return two decades later and stand at that podium to speak on the global epidemiology of IBD.

CCAG@CanGastroAssn · Feb 28

Excellent presentations at the JCAG Clinical Symposium - From Local Impact to Global Health: Canadian Research Goes International #cddwclm2025

3.0K

Gil Kaplan MD MPH Retweeted

Healio Gastroenterology@HealioGastro · Jan 27, 2024

The cost 💰of #IBD care: 👉🏻Average cost per patient increased from $8,477 in 2009➡️$15,786 in 2018-2019. 👉🏻Annual cost for at least one #biologic 💊 increased while the cost of nonbiologic medications decreased. @Stephanie_Epi #CCCongress24 ⬇️⬇️ healio.com/news/gastroent…

2.0K